Evidence map›Paper›PMID 35296284›Full record

ArticleBMC cancer2022

New method for determining breast cancer recurrence-free survival using routinely collected real-world health data.

Hyunmin Jung, Mingshan Lu, May Lynn Quan, Winson Y Cheung, Shiying Kong, Sasha Lupichuk, Yuanchao Feng, Yuan Xu

Abstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hyunmin JungDepartment of Economics, Faculty of Arts, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.
Mingshan LuDepartment of Economics, Faculty of Arts, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.
May Lynn QuanDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada.
Winson Y CheungDepartment of Economics, Faculty of Arts, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.
Shiying KongDepartment of Economics, Faculty of Arts, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada.
Sasha LupichukDepartment of Oncology, Cumming School of Medicine, University of Calgary, Tom Baker Cancer Centre, 1331 29th St NW, Calgary, AB, T2N 4N2, Canada.
Yuanchao FengDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada.
Yuan XuDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, 3D10 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada. yuxu@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn cancer survival analyses using population-based data, researchers face the challenge of ascertaining the timing of recurrence. We previously developed algorithms to identify recurrence of breast cancer. This is a follow-up study to detect the timing of recurrence.

methodsHealth events that signified recurrence and timing were obtained from routinely collected administrative data. The timing of recurrence was estimated by finding the timing of key indicator events using three different algorithms, respectively. For validation, we compared algorithm-estimated timing of recurrence with that obtained from chart-reviewed data. We further compared the results of cox regressions models (modeling recurrence-free survival) based on the algorithms versus chart review.

resultsIn total, 598 breast cancer patients were included. 121 (20.2%) had recurrence after a median follow-up of 4 years. Based on the high accuracy algorithm for identifying the presence of recurrence (with 94.2% sensitivity and 79.2% positive predictive value), the majority (64.5%) of the algorithm-estimated recurrence dates fell within 3 months of the corresponding chart review determined recurrence dates. The algorithm estimated and chart-reviewed data generated Kaplan-Meier (K-M) curves and Cox regression results for recurrence-free survival (hazard ratios and P-values) were very similar.

conclusionThe proposed algorithms for identifying the timing of breast cancer recurrence achieved similar results to the chart review data and were potentially useful in survival analysis.

Indexed as

Breast NeoplasmsFemaleFollow-Up StudiesGlobal HealthHumansNeoplasm Recurrence, LocalProportional Hazards ModelsBreast cancerIdentification algorithmReal-world dataSurvival analysisTiming of recurrence

Identifiers

PMID35296284
PMCPMC8925135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.